BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou G, Yuan X, Li Y, Hou G, Liu X. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway. Invest New Drugs 2020;38:329-39. [PMID: 31102118 DOI: 10.1007/s10637-019-00781-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao Q, Feng J, Liu W, Wen C, Wu Y, Liao Q, Zou L, Sui X, Xie T, Zhang J, Hu Y. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev 2022;188:114445. [PMID: 35820601 DOI: 10.1016/j.addr.2022.114445] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Jin X, Mei Y, Shen Z, Zhu J, Xing S, Yang H, Liang G, Zheng X. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation. Phytomedicine 2022;101:154087. [DOI: 10.1016/j.phymed.2022.154087] [Reference Citation Analysis]
3 Lu T, Zheng C, Fan Z. Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression. Pharmaceutical Biology 2022;60:1011-21. [DOI: 10.1080/13880209.2022.2069823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Danesh Pouya F, Rasmi Y, Nemati M. Signaling Pathways Involved in 5-FU Drug Resistance in Cancer. Cancer Invest 2022;:1-28. [PMID: 35320055 DOI: 10.1080/07357907.2022.2055050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lin S, Yan Z, Tang Q, Zhang S. Ubiquitin-associated protein 2 like (UBAP2L) enhances growth and metastasis of gastric cancer cells. Bioengineered 2021;12:10232-45. [PMID: 34823423 DOI: 10.1080/21655979.2021.1982308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ding Q, Niu P, Zhu Y, Chen H, Shi D. Cardamonin inhibits the expression of P-glycoprotein and enhances the anti-proliferation of paclitaxel on SKOV3-Taxol cells. J Nat Med 2021. [PMID: 34751899 DOI: 10.1007/s11418-021-01583-1] [Reference Citation Analysis]
7 Constantinescu T, Lungu CN. Anticancer Activity of Natural and Synthetic Chalcones. Int J Mol Sci 2021;22:11306. [PMID: 34768736 DOI: 10.3390/ijms222111306] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Hu J, Li P, Shi B, Tie J. Effects and Mechanisms of Saikosaponin D Improving the Sensitivity of Human Gastric Cancer Cells to Cisplatin. ACS Omega 2021;6:18745-55. [PMID: 34337214 DOI: 10.1021/acsomega.1c01795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 James S, Aparna JS, Babu A, Paul AM, Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN, Mohammed S, Reshmi G, Harikumar KB. Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer. Biomolecules 2021;11:661. [PMID: 33947113 DOI: 10.3390/biom11050661] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Wang Z, Liu H, Hu Q, Shi L, Lü M, Deng M, Luo G. Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway. J Cancer 2021;12:3597-610. [PMID: 33995637 DOI: 10.7150/jca.55519] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Zhao Y, Wang C, Goel A. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis 2021;42:814-25. [PMID: 33822896 DOI: 10.1093/carcin/bgab027] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Wu L, Cai S, Deng Y, Zhang Z, Zhou X, Su Y, Xu D. PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. Int Immunopharmacol 2021;94:107443. [PMID: 33581579 DOI: 10.1016/j.intimp.2021.107443] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
13 Chen Q, Lei J, Zhou J, Ma S, Huang Q, Ge B. Chemopreventive effect of 4'-hydroxychalcone on intestinal tumorigenesis in ApcMin mice. Oncol Lett 2021;21:213. [PMID: 33510814 DOI: 10.3892/ol.2021.12474] [Reference Citation Analysis]
14 Daimary UD, Parama D, Rana V, Banik K, Kumar A, Harsha C, Kunnumakkara AB. Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases. Current Research in Pharmacology and Drug Discovery 2021;2:100008. [DOI: 10.1016/j.crphar.2020.100008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
15 Bailly C, Vergoten G. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis. Life Sci 2020;263:118601. [PMID: 33086122 DOI: 10.1016/j.lfs.2020.118601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Pui Ping C, Akhtar MN, Israf DA, Perimal EK, Sulaiman MR. Possible Participation of Ionotropic Glutamate Receptors and l-Arginine-Nitric Oxide-Cyclic Guanosine Monophosphate-ATP-Sensitive K+ Channel Pathway in the Antinociceptive Activity of Cardamonin in Acute Pain Animal Models. Molecules 2020;25:E5385. [PMID: 33217904 DOI: 10.3390/molecules25225385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, Vikkurthi R, Devi TB, Gupta SC, Kunnumakkara AB. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.06.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
18 Nawaz J, Rasul A, Shah MA, Hussain G, Riaz A, Sarfraz I, Zafar S, Adnan M, Khan AH, Selamoglu Z. Cardamonin: A new player to fight cancer via multiple cancer signaling pathways. Life Sci 2020;250:117591. [PMID: 32224026 DOI: 10.1016/j.lfs.2020.117591] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
19 Jin J, Qiu S, Wang P, Liang X, Huang F, Wu H, Zhang B, Zhang W, Tian X, Xu R, Shi H, Wu X. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. J Exp Clin Cancer Res 2019;38:377. [PMID: 31455352 DOI: 10.1186/s13046-019-1351-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
20 Russi S, Verma HK, Laurino S, Mazzone P, Storto G, Nardelli A, Zoppoli P, Calice G, La Rocca F, Sgambato A, Lucci V, Falco G, Ruggieri V. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Int J Mol Sci 2019;20:E3736. [PMID: 31370155 DOI: 10.3390/ijms20153736] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]